Mortality News and Research

RSS

Serelaxin reduces occurrence of in-hospital worsening heart failure

Serelaxin reduces the occurrence of in-hospital worsening heart failure by almost half in patients admitted for acute heart failure, according to the RELAX-AHF trial. The results were presented for the first time today at ESC Congress by co-principal investigator Professor John R. Teerlink.

1 Sep 2014

New polypill increases adherence to treatment following myocardial infarction

A new polypill increases adherence to treatment following a myocardial infarction (MI), according to results from the FOCUS Study presented for the first time at ESC Congress 2014 today by principal investigator Dr Valentin Fuster, director of Mount Sinai Heart in New York, US.

1 Sep 2014

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Mortality and morbidity of atrial fibrillation (AF) patients remains high at one year despite good use of oral anticoagulants, according to the one year follow up of the Atrial Fibrillation General Pilot Registry.

1 Sep 2014

Darapladib drug fails to reduce risk of recurrent major coronary events

In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable angina), use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 (believed to play a role in the development of atherosclerosis) did not reduce the risk of recurrent major coronary events, according to a study published by JAMA.

1 Sep 2014

Complete revascularisation leads to better outcomes in patients with heart attack

In patients being treated for heart attack, complete revascularisation of all significantly blocked arteries leads to better outcomes compared to a strategy of unblocking just the "culprit" artery responsible for the heart attack, according to a new study presented today at ESC Congress 2014.

1 Sep 2014

Antihypertensive therapy decreases risk of mortality, CV events, strokes in older adults

Antihypertensive therapy reduces the risk of cardiovascular (CV) events, strokes and mortality in hypertensive older adults, according to research presented at ESC Congress 2014 today by Dr Maciej Ostrowski from Poland.

1 Sep 2014

Study: Resistant hypertension increases risk of stroke in female and elderly patients

Resistant hypertension increases the risk of stroke by 35% in women and 20% in elderly Taiwanese patients, according to research presented at ESC Congress today by Dr Kuo-Yang Wang from Taiwan.

1 Sep 2014

University of Leicester research sniffs out smell of disease in feces

A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria C. diff, that causes diarrhoea, temperature and stomach cramps, has been developed by a team at the University of Leicester.

1 Sep 2014

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product (QIDP) status from U.S. Food & Drug Administration.

1 Sep 2014

Tea significantly lowers risk of non-CV death, study reveals

Drinking tea reduces non-cardiovascular mortality by 24%, reveals a study in 131 000 people presented at ESC Congress today by Professor Nicolas Danchin from France.

31 Aug 2014

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

Heart failure patients with iron deficiency can experience significant and sustainable improvements in functional capacity and quality of life as well as reduced risk of hospital admission for worsening heart failure by receiving just one to two intravenous doses of an iron supplement, according to the results of a study presented today at ESC Congress 2014.

30 Aug 2014

Investigational LCZ696 drug: A real breakthrough for patients with heart failure

An investigational new heart failure drug could be poised to change the face of cardiology based on Hot Line results presented today at ESC Congress 2014.

30 Aug 2014

ESC launches first recommendations on use of all new oral anticoagulants in pulmonary embolism

The first recommendations on the use of all new oral anticoagulants in pulmonary embolism are published today in new ESC Guidelines.

30 Aug 2014

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

The first comprehensive ESC Guidelines on aortic diseases are published today. They are presented at ESC Congress 2014 by Task Force Chairpersons Professor Raimund Erbel (Germany) and Professor Victor Aboyans (France).

30 Aug 2014

KIT spinoff amcure develops tumor therapeutic agents to reduce mortality rate

There is an urgent need for medical agents to treat metastatic tumors. In case of pancreatic cancer, one of the most aggressive types of cancer that is often detected late, 95% of the patients die within five years after the diagnosis.

30 Aug 2014

Rice University researchers confirm potent synthesis of natural tetracycline

A fortuitous collaboration at Rice University has led to the total synthesis of a recently discovered natural antibiotic.

29 Aug 2014

Bacteremia linked to worse in-hospital course, outcomes in patients with pneumonia

The presence of bacteremia in patients with pneumonia is associated with a worse in-hospital course of illness and poorer patient outcomes, show Spanish findings.

28 Aug 2014

Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Some 30 percent of all positive hospital blood culture samples are discarded every day because they're "contaminated" - they reflect the presence of skin germs instead of specific disease-causing bacteria.

28 Aug 2014

Patients with intestinal polyps have lower risk of dying from cancer

Patients with intestinal polyps have a lower risk of dying from cancer than previously thought, according to Norwegian researchers.

28 Aug 2014

Educating clinicians can reduce sepsis patient mortality and lower hospital costs

Sepsis is the tenth leading cause of death in the United States, and new research published in the Journal for Healthcare Quality (JHQ) shows that educating clinicians about expediting diagnosis and administration of antibiotics can reduce sepsis patient mortality and lower hospital costs.

27 Aug 2014

Mortality News and Research

Serelaxin reduces occurrence of in-hospital worsening heart failure

New polypill increases adherence to treatment following myocardial infarction

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Darapladib drug fails to reduce risk of recurrent major coronary events

Complete revascularisation leads to better outcomes in patients with heart attack

Antihypertensive therapy decreases risk of mortality, CV events, strokes in older adults

Study: Resistant hypertension increases risk of stroke in female and elderly patients

University of Leicester research sniffs out smell of disease in feces

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Tea significantly lowers risk of non-CV death, study reveals

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

Investigational LCZ696 drug: A real breakthrough for patients with heart failure

ESC launches first recommendations on use of all new oral anticoagulants in pulmonary embolism

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

KIT spinoff amcure develops tumor therapeutic agents to reduce mortality rate

Rice University researchers confirm potent synthesis of natural tetracycline

Bacteremia linked to worse in-hospital course, outcomes in patients with pneumonia

Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Patients with intestinal polyps have lower risk of dying from cancer

Educating clinicians can reduce sepsis patient mortality and lower hospital costs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News